Washington: Measuring the ratio of two enzymes in maternal plasma is an effective indicator for the early detection of fetal gender, a new study has suggested. The new study describes findings that could lead to a non-invasive test that would let expecting mothers know the sex of their baby as early as the first trimester. Researchers from South Korea discovered that various ratios of the enzymes DYS14 and GAPDH, which can be extracted from a pregnant mother’s blood, indicate if the baby will be a boy or a girl. “Generally, early fetal gender determination has been performed by invasive procedures such as chorionic villus sampling or amniocentesis,” Hyun Mee Ryu, a researcher involved in the work from the Department of Obstetrics and Gynocology at Cheil General Hospital and Women’s Healthcare Center at the KwanDong University School of Medicine in Seoul, Korea, said. “However, these invasive procedures still carry a one to two percent risk of miscarriage and cannot be performed until 11 weeks of gestation. Moreover, reliable determination of fetal gender using ultrasonography cannot be performed in the first trimester, because the development of external genitalia is not complete.
Scientists crack ancient bone disease
Nap-deprived tots at risk of lifelong mood-related problems